NAPG
Gamma-soluble NSF attachment protein
Also known as: SNAG_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99747
- Gene
- NAPG
- Ensembl
- ENSG00000134265
- Chromosome
- 18
- Canonical length
- 312 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes soluble NSF attachment protein gamma. The soluble NSF attachment proteins (SNAPs) enable N-ethyl-maleimide-sensitive fusion protein (NSF) to bind to target membranes. NSF and SNAPs appear to be general components of the intracellular membrane fusion apparatus, and their action at specific sites of fusion must be controlled by SNAP receptors particular to the membranes being fused. The product of this gene mediates platelet exocytosis and controls the membrane fusion events of this process.[provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
312 residues, UniProt reviewed canonical sequence.
>Q99747|NAPG
1 MAAQKINEGL EHLAKAEKYL KTGFLKWKPD YDSAASEYGK AAVAFKNAKQ FEQAKDACLR
61 EAVAHENNRA LFHAAKAYEQ AGMMLKEMQK LPEAVQLIEK ASMMYLENGT PDTAAMALER
121 AGKLIENVDP EKAVQLYQQT ANVFENEERL RQAVELLGKA SRLLVRGRRF DEAALSIQKE
181 KNIYKEIENY PTCYKKTIAQ VLVHLHRNDY VAAERCVRES YSIPGFNGSE DCAALEQLLE
241 GYDQQDQDQV SDVCNSPLFK YMDNDYAKLG LSLVVPGGGI KKKSPATPQA KPDGVTATAA
301 DEEEDEYSGG LCLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NAPG can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 30 nTPM
- spinal cord: 27 nTPM
- hippocampal formation: 25 nTPM
- cerebellum: 24 nTPM
- midbrain: 23 nTPM
- basal ganglia: 22 nTPM
Single-cell type
- esophageal apical cells: 147 nCPM
- conjunctival goblet cells: 132 nCPM
- respiratory ionocytes: 130 nCPM
- esophageal suprabasal cells: 106 nCPM
- urothelial cells: 102 nCPM
- endometrial secretory cells: 101 nCPM
Immune cell
- eosinophil: 14 nTPM
- basophil: 13 nTPM
- neutrophil: 8.4 nTPM
- memory B-cell: 7.7 nTPM
- non-classical monocyte: 6.7 nTPM
- intermediate monocyte: 6.6 nTPM
Brain region
- pons: 51 nTPM
- medulla oblongata: 38 nTPM
- hippocampal formation: 38 nTPM
- cerebral cortex: 30 nTPM
- white matter: 30 nTPM
- cerebellum: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.55
- gnomAD pLI
- 0.08
- gnomAD missense Z
- 0.57
- DepMap mean gene effect
- -0.75
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- intra-Golgi vesicle-mediated transport
- intracellular protein transport
- membrane fusion
- protein stabilization
- protein-containing complex assembly
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NAPG in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NAPG as an antibody target. Whether an autoantibody or antibody against NAPG could matter depends on whether native NAPG is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NAPG is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NAPG as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...